⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6824660 | 0.78 | — | — | |
| SCHEMBL6823712 | 0.78 | — | — | |
| SCHEMBL6823719 | 0.78 | — | — | |
| SCHEMBL6827127 | 0.68 | LAP3 (0.44) | — | |
| Phosphoric Acid SCHEMBL27667326 | 0.66 | — | — | |
| SCHEMBL2609685 | 0.64 | — | — | |
| SCHEMBL5918527 | 0.64 | — | — | |
| SCHEMBL5435151 | 0.64 | — | — | |
| Phosphoramidic Acid SCHEMBL4439626 | 0.64 | — | — | |
| SCHEMBL1884027 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009145716-A1 | NEW PHARMACEUTICAL FORMULATION USEFUL IN GERD THERAPY | ASTRAZENECA AB (SE) | 2009-12-03 | — | — | WO | claimed |
| WO-2009145716-A1 | NEW PHARMACEUTICAL FORMULATION USEFUL IN GERD THERAPY | ASTRAZENECA AB (SE) | 2009-12-03 | — | — | WO | disclosed |